Form 4 for SGHT Sight Sciences, Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-26 · accession 0001193125-25-337102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-30 | 2025-12-26 | SGHT | Badawi David | CTO, Dir | M - OptEx | $0.23 | +21.3K | 1.93M | +1% | +$4,892 |
| D | 2025-12-30 | 2025-12-26 | SGHT | Badawi David | CTO, Dir | M - OptEx | $0.00 | -21.3K | 21.3K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-26 | M | A | 21,270 | $0.23 | 1,926,769 | D | — | — | (F1) Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. (F3) The Reporting Person previously reported a grant of 28,100 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 39,100 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 43,375 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. (F2) Includes (i) 1,758,996 shares of common stock, and (ii) 167,773 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-26 | M | D | 21,270 | $0.00 | 21,270 | D | $0.23 · — to 2026-02-28 | 21,270 Common Stock | (F1) Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. (F4) The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020. |